Tarsons Products
NSE: TARSONS · ISIN INE144Z01023 · Healthcare
₹312.50−7.75 (−2.42%)
Monday 9 November, 12:19 IST. Delayed. Source: Yahoo Finance.
Price chart
₹312.50 −7.75 (−2.42%) today
The day
- Previous close
- ₹320.25
- Open
- ₹318.00
- Day high
- ₹320.75
- Day low
- ₹310.00
Listed on NSE since 26 November 2021.
Key numbers
- Market value
- ₹1,662.70 Cr
- P/E (trailing)
- 150.97
- EPS (trailing)
- ₹2.07
- Price to book
- 2.61
- Dividend yield
- 0.00%
- Debt to equity
- 0.62
- Profit margin
- 2.5%
- Beta
- 0.33
- Volume today
- 19,737
- Average volume
- 4.48 L
Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.
Revenue and profit
| Year | Revenue | Net profit |
|---|---|---|
| FY23 | ₹281.36 Cr | ₹80.71 Cr |
| FY24 | ₹294.74 Cr | ₹42.64 Cr |
| FY25 | ₹390.63 Cr | ₹29.77 Cr |
| FY26 | ₹420.62 Cr | ₹14.32 Cr |
Source: Yahoo Finance, from annual reports. Consolidated where reported.
Quarterly results
| Quarter | Revenue | Net profit | Profit vs year ago |
|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | ₹110 Cr | ₹0 | – |
| Q4 FY26Jan–Mar 2026Audited | ₹121 Cr | ₹0 | – |
| Q3 FY26Oct–Dec 2025 | ₹108 Cr | ₹0 | – |
| Q2 FY26Jul–Sep 2025 | ₹102 Cr | ₹0 | – |
| Q1 FY26Apr–Jun 2025 | ₹91 Cr | ₹0 | – |
| Q4 FY25Jan–Mar 2025Audited | ₹113 Cr | ₹0 | – |
Source: Tarsons Products’s results filed with NSE, consolidated (the whole group). Net profit is the share of Tarsons Products’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.
Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.
Balance sheet
| As on | March 2026 | September 2025 |
|---|---|---|
| Fixed assets | ₹815 Cr | ₹755 Cr |
| Inventories | ₹130 Cr | ₹135 Cr |
| Owed by customers | ₹85 Cr | ₹73 Cr |
| Cash and equivalents | ₹23 Cr | ₹26 Cr |
| Total assets | ₹1,186 Cr | ₹1,164 Cr |
| Borrowings | ₹383 Cr | ₹385 Cr |
| Total liabilities | ₹551 Cr | ₹537 Cr |
| Shareholders’ equity | ₹635 Cr | ₹627 Cr |
Source: Tarsons Products’s half-yearly statements of assets and liabilities filed with NSE, consolidated. Companies file these every September and March.
About Tarsons Products
Tarsons Products Limited manufactures and trades in scientific plastic labware products in India and internationally. The company offers assay plates, biohazard and safetyware, bioprocessing solutions, bottles and carboys, boxes and racks, cell culture ware, centrifuge ware, clamps and stands, clinical and microbiology products, cryoware, desiccators, tubings and connectors, filtration products, general labware, genomics and PCR consumables, laboratory equipment, laboratory utilities, liquid handling consumables, liquid handling reusables, magnetic stirrer bars, PP storage plates, sampling aids, vials and tubes, and volumetric reusables. Its products are used in molecular biology, cell culture, genomics, proteomics, and immunology. Tarsons Products Limited was incorporated in 1983 and is headquartered in Kolkata, India.
- Industry
- Medical Instruments & Supplies
- Based in
- Kolkata
- Employees
- 1,108
Company website · Profile: Yahoo Finance
In the news
All newsNo headlines name Tarsons Products in the last day or two.
Dividends and corporate actions
All companies- Annual General Meeting/Dividend - Rs 2 Per Share
Dividend · ex-date 20 September 2024
- Annual General Meeting
Action · ex-date 7 July 2023
- Annual General Meeting
Action · ex-date 21 July 2022
Source: NSE. Latest first.
Information only, not investment advice. Prices are delayed.